De Brauw advised underwriters on secondary offering of shares in NewAmsterdam Pharma. NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients...
De Brauw advised underwriters on secondary offering of shares in NewAmsterdam Pharma. NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients...
You must be a Standard 1 Year member to access this content.